Strong Operating Cash Flow in Health Care
Companies with positive operating cash flow, demonstrating that core business operations generate real cash regardless of accounting adjustments.
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
140 Companies Meeting Criteria
Showing 1–50 of 140 companies, ranked by Operating CF.
| # | Company | Operating CF | Free Cash Flow | Net Income |
|---|---|---|---|---|
| 1 | UNHUnitedHealth Group | $19.7B | $16.1B | $17.6B |
| 2 | HCAHCA Healthcare | $12.6B | $7.7B | $6.3B |
| 3 | CVSCVS Health | $10.6B | $7.8B | $455M |
| 4 | CICigna | $9.6B | $8.4B | $6.5B |
| 5 | ABTAbbott Laboratories | $9.6B | $7.4B | $14.0B |
| 6 | TMOThermo Fisher Scientific | $7.8B | $6.3B | $6.6B |
| 7 | MDTMedtronic | $6.8B | $5.2B | $4.7B |
| 8 | DHRDanaher Corporation | $6.4B | $5.3B | $3.5B |
| 9 | MCKMcKesson Corporation | $6.2B | $5.7B | $3.3B |
| 10 | CNCCentene Corporation | $5.1B | $4.3B | -$5.3B |
| 11 | SYKStryker Corporation | $5.0B | $4.3B | $3.0B |
| 12 | BSXBoston Scientific | $4.5B | $3.7B | $2.8B |
| 13 | ELVElevance Health | $4.3B | $3.2B | $5.5B |
| 14 | CORCencora | $3.9B | $3.2B | $1.6B |
| 15 | THCTenet Health | $3.5B | $2.5B | $1.1B |
| 16 | BDXBecton Dickinson | $3.4B | $2.7B | $1.7B |
| 17 | ISRGIntuitive Surgical | $3.0B | $2.5B | $2.7B |
| 18 | IQVIQVIA | $2.7B | $2.1B | $1.3B |
| 19 | CAHCardinal Health | $2.4B | $1.9B | $1.6B |
| 20 | GEHCGE HealthCare | $2.0B | $1.5B | $2.2B |
| 21 | DVADaVita | $1.9B | $1.3B | $772M |
| 22 | DGXQuest Diagnostics | $1.9B | $1.4B | $969M |
| 23 | UHSUniversal Health Services | $1.9B | $849M | $1.4B |
| 24 | RMDResMed | $1.8B | $1.7B | $1.4B |
| 25 | RSMDFResMed | $1.8B | $1.7B | $1.4B |
| 26 | MDLNMedline Inc. | $1.7B | $1.3B | - |
| 27 | ZBHZimmer Biomet | $1.7B | $1.5B | $805M |
| 28 | LHLabcorp | $1.6B | $1.2B | $855M |
| 29 | EWEdwards Lifesciences | $1.6B | $1.3B | $4.2B |
| 30 | AAgilent Technologies | $1.6B | $1.2B | $1.3B |
| 31 | DXCMDexcom | $1.4B | $1.1B | $721M |
| 32 | IDXXIdexx Laboratories | $1.2B | $1.1B | $1.0B |
| 33 | EHCEncompass Health | $1.2B | $439M | - |
| 34 | OSCROscar Health, Inc. | $1.1B | $1.1B | -$244M |
| 35 | ILMNIllumina, Inc. | $1.1B | $931M | $702M |
| 36 | HOLXHologic | $1.1B | $998M | $566M |
| 37 | STESteris | $973M | $613M | $615M |
| 38 | MTDMettler Toledo | $956M | $849M | $836M |
| 39 | HUMHumana | $921M | $375M | $1.3B |
| 40 | BAXBaxter International | $845M | $332M | -$649M |
| 41 | COOCooper Companies (The) | $796M | $434M | $375M |
| 42 | WSTWest Pharmaceutical Services | $755M | $469M | $492M |
| 43 | GMEDGlobus Medical | $753M | $589M | - |
| 44 | CRLCharles River Laboratories | $738M | $518M | -$82M |
| 45 | MEDPMedpace | $713M | $682M | $433M |
| 46 | HSICHenry Schein | $712M | $573M | $391M |
| 47 | WATWaters Corporation | $653M | $540M | $638M |
| 48 | AVTRAvantor | $624M | $495M | -$82M |
| 49 | AHCOAdaptHealth Corp. | $602M | $219M | $90M |
| 50 | ALGNAlign Technology | $593M | $491M | $378M |
Understanding Operating Cash Flow
Operating cash flow (OCF) measures cash generated from a company's core business activities. Unlike net income, OCF strips out non-cash items like depreciation and stock-based compensation, revealing the actual cash a business produces. Consistently positive OCF is essential for funding operations, investments, and shareholder returns without relying on external financing.
Operating Cash Flow > $0
Results are based on SEC EDGAR filings. Companies with missing, unreliable, or extreme outlier values are excluded from screening.
Related Rankings
See the top companies ranked by these related metrics